Use of fibrates in the metabolic syndrome: A review

doi:10.4239/wjd.v7.i5.74

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (12406)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

983

WORD

438

HTML

7118

Figures (1-3)

347

Tables (1-2)

492

Sum=9378

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1397

Download

1631

Sum=3028

Mar 10, 2016 (publication date) through Dec 28, 2024

Times Cited of This Article

Times Cited (49)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Diabetes. Mar 10, 2016; 7(5): 74-88
Published online Mar 10, 2016. doi: 10.4239/wjd.v7.i5.74

Full Size Figure Download Figure

Figure 2 Change in high-density lipoprotein cholesterol following fibrate treatment stratified by pre-treatment high-density lipoprotein cholesterol concentrations in 248 patients (adapted from Ramachandran et al[86]) - permission received via Rightslink. HDL-C: High density lipoprotein cholesterol.

Citation: Shipman KE, Strange RC, Ramachandran S. Use of fibrates in the metabolic syndrome: A review. World J Diabetes 2016; 7(5): 74-88
URL: https://www.wjgnet.com/1948-9358/full/v7/i5/74.htm
DOI: https://dx.doi.org/10.4239/wjd.v7.i5.74